Home
Storia in 1 fonti
ICON audit finds overstated revenue; Secretome and Psilera raise cash
ICON audit found revenue was overstated in 2023 and 2024; Psilera and Secretome Therapeutics raise funds.
Raccontata da
endpoints.news
Timeline cronologica
- ·
ICON audit finds overstated revenue; Secretome and Psilera raise cash
ICON audit found revenue was overstated in 2023 and 2024; Psilera and Secretome Therapeutics raise funds.
- ·
AstraZeneca seeks path for failed antibody; Imfinzi, Tremfya get label expansions
AstraZeneca seeks a narrower path for failed antibody; Imfinzi and Tremfya label expansions